Andrew J Murphy1, Yina Li, Joshua B Pietsch, Chin Chiang, Harold N Lovvorn. 1. Department of Pediatric Surgery, Vanderbilt University Children's Hospital, Doctor's Office Tower, Suite 7102, 2200 Children's Way, Nashville, TN 37232-9780, USA. andrew.j.murphy@vanderbilt.edu
Abstract
PURPOSE: The NOG protein is a secretory antagonist of bone morphogenetic proteins (BMPs). Nog-/- mouse embryos demonstrate proximal esophageal atresia (EA) and distal tracheoesophageal fistula (TEF) compatible with the most common configuration of EA/TEF observed in humans. Four microdeletions that span the NOG locus at 17q22 have been described in human patients having EA/TEF. We investigated the incidence of point mutations in the coding region of the NOG gene in human EA/TEF. METHODS: DNA was collected from 50 patients previously treated for EA/TEF. PCR was used to amplify the coding region of NOG. To detect single nucleotide polymorphisms (SNPs), amplicons were subjected to temperature gradient capillary electrophoresis (TGCE). Candidate SNPs were directly sequenced. RESULTS: TGCE analysis revealed a SNP in the coding region of NOG in 1 of 50 patients (2%). DNA sequencing revealed a synonymous SNP at position 468 (C-T) of the NOG coding region. CONCLUSION: SNPs in the coding region of the NOG gene are identified infrequently in human cases of EA/TEF. Further investigation of SNPs in the promoter region of NOG is warranted, as is the effect of synonymous SNPs on NOG mRNA stability.
PURPOSE: The NOG protein is a secretory antagonist of bone morphogenetic proteins (BMPs). Nog-/- mouse embryos demonstrate proximal esophageal atresia (EA) and distal tracheoesophageal fistula (TEF) compatible with the most common configuration of EA/TEF observed in humans. Four microdeletions that span the NOG locus at 17q22 have been described in humanpatients having EA/TEF. We investigated the incidence of point mutations in the coding region of the NOG gene in humanEA/TEF. METHODS: DNA was collected from 50 patients previously treated for EA/TEF. PCR was used to amplify the coding region of NOG. To detect single nucleotide polymorphisms (SNPs), amplicons were subjected to temperature gradient capillary electrophoresis (TGCE). Candidate SNPs were directly sequenced. RESULTS: TGCE analysis revealed a SNP in the coding region of NOG in 1 of 50 patients (2%). DNA sequencing revealed a synonymous SNP at position 468 (C-T) of the NOG coding region. CONCLUSION: SNPs in the coding region of the NOG gene are identified infrequently in human cases of EA/TEF. Further investigation of SNPs in the promoter region of NOG is warranted, as is the effect of synonymous SNPs on NOG mRNA stability.
Authors: T Takahashi; I Takahashi; M Komatsu; Y Sawaishi; K Higashi; G Nishimura; H Saito; G Takada Journal: Clin Genet Date: 2001-12 Impact factor: 4.438
Authors: Y Gong; D Krakow; J Marcelino; D Wilkin; D Chitayat; R Babul-Hirji; L Hudgins; C W Cremers; F P Cremers; H G Brunner; K Reinker; D L Rimoin; D H Cohn; F R Goodman; W Reardon; M Patton; C A Francomano; M L Warman Journal: Nat Genet Date: 1999-03 Impact factor: 38.330
Authors: D Krakow; K Reinker; B Powell; R Cantor; M A Priore; A Garber; R S Lachman; D L Rimoin; D H Cohn Journal: Am J Hum Genet Date: 1998-07 Impact factor: 11.025
Authors: Kathleen A Williamson; Ann M Hever; Joe Rainger; R Curtis Rogers; Alex Magee; Zdenek Fiedler; Wee Teik Keng; Freddie H Sharkey; Niolette McGill; Clare J Hill; Adele Schneider; Mario Messina; Peter D Turnpenny; Judy A Fantes; Veronica van Heyningen; David R FitzPatrick Journal: Hum Mol Genet Date: 2006-03-16 Impact factor: 6.150
Authors: Carolina Pinzon-Guzman; Sreedhara Sangadala; Katherine M Riera; Evgenya Y Popova; Elizabeth Manning; Won Jae Huh; Matthew S Alexander; Julia S Shelton; Scott D Boden; James R Goldenring Journal: J Clin Invest Date: 2020-08-03 Impact factor: 14.808
Authors: Nicole A Edwards; Vered Shacham-Silverberg; Leelah Weitz; Paul S Kingma; Yufeng Shen; James M Wells; Wendy K Chung; Aaron M Zorn Journal: Dev Biol Date: 2021-05-21 Impact factor: 3.582